Kores India began its operations in 1956. Today, Kores India is a highly diversified business conglomerate, excelling across multiple industry verticals, including Office Products, Pharmaceuticals, Foundry, Engineering, Infrastructure, and Business Automation Products. Renowned for delivering high-value offerings, Kores India consistently drives innovation and excellence in every sector we serve.
ABOUT US
Pioneering venture in specialty chemicals
From Theophylline derivatives to anti-diabetic intermediates, our unwavering focus on innovation ensures the delivery of high-quality solutions. We operate seven cutting-edge manufacturing blocks dedicated to producing premium pharmaceutical products tailored to address various diseases.
WHO WE ARE. WHAT WE DO
OUR MISSION
TO BECOME THE FAST API-PHARMA ORGANIZATION BY CONSISTENTLY ENHANCING OUR PROCESSES & SYSTEMS TO ENABLE THE COST EFFECTIVE PRODUCTION THAT COMPLY WITH THE HIGHEST REGULATORY STANDARDS.
WHO WE ARE. WHAT WE DO
OUR VISION
TO BECOME COST EFFECTIVE & CUSTOMER FRIENDLY QUALITY ORIENTED apI & pHARMA ADVANCE INTERMEDIATES ORGANIZATION. WE WILL FOLLOW AUTOMATION & INNOVATION FOR OUR GROWTH & EXPANSION.
ACCREDIATION
Foreign Drug Manufacturer (FDM) Certificate by the Minister of Health , Labour & Welfare, Japan.
ISO 9001:2008
Certified by TUV NORD Cert Gmbh, Germany
Manufacturing facility is approved by Maharashtra State FDA, India.
Holding Export House Certificate, Government of India.
Audited and approved by European Customers for APIs and Intermediates
R&D Centre recognised by Ministry of Science, Department of Scientific Technology & Industrial Research, GOI
REACTION CAPABILITIES
The plant has the capacity to develop and execute a range of chemical processes
Ethoxylation
Chlorination
Bromination
Reduction
Hydrogenation
Oxidation
Alkylation
Top Products
Countries Catered
Countries Catered
GET IN TOUCH
Schedule a call today. Explore how our APIs can enhance your products.